Currently out of the existing stock ratings of Craig Hettenbach, 93 are a HOLD (40.43%), 32 are a SELL (13.91%), 105 are a BUY (45.65%).

Craig Hettenbach

Work Performance Price Targets & Ratings Chart

Analyst Craig Hettenbach, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 68.92% that have a potential upside of 16.66% achieved within 171 days.

Craig Hettenbach’s has documented 550 price targets and ratings displayed on 26 stocks. The coverage is on Technology, Healthcare sectors.

Most recent stock forecast was given on SLAB, Silicon Laboratories at 06-Aug-2025.

Wall Street Analyst Craig Hettenbach

Analyst best performing recommendations are on WOLF (WOLFSPEED).
The best stock recommendation documented was for CREE (CREE) at 4/26/2021. The price target of $100 was fulfilled within 3 days with a profit of $19.02 (15.98%) receiving and performance score of 53.27.

Average potential price target upside

of $47.89 (14.24%) on HCA (HCA HOLDINGS).
of $22.55 (13.32%) on TXN (TEXAS INSTRUMENTS).
of $21.35 (20.64%) on NXPI (NXP SEMICONDUCTORS NV).

ADI Analog Devices APH Amphenol AVGO Broadcom CREE Cree CY Cypress Semiconductor MCHP Microchip Technology NXPI NXP Semiconductors NV ON ON Semiconductor PI Impinj QRVO Qorvo ST Sensata Technologies Holding NV SWKS Skyworks Solutions TEL TE Connectivity Ltd TXN Texas Instruments DH Definitive Healthcare Corp WOLF Wolfspeed SLAB Silicon Laboratories SHCR Sharecare RCM R1 RCM MODN Model N DOCS Doximity AMWL American Well Corp VEEV Veeva Systems GDRX Goodrx Holdings HCA HCA Holdings ARDT Ardent Health Partners

Show more stocks

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Joseph Moore (MORGAN STANLEY)